Arcellx, Inc. (ACLX)
64.80
-1.47
(-2.22%)
USD |
NASDAQ |
Jan 12, 16:00
64.80
0.00 (0.00%)
After-Hours: 18:44
Arcellx Research and Development Expense (Quarterly): 35.09M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.334B |
| Johnson & Johnson | 3.693B |
| Amicus Therapeutics, Inc. | 23.42M |
| Relmada Therapeutics, Inc. | 4.036M |
| Invivyd, Inc. | 8.046M |